See more : Crown Castle Inc. (CCI) Income Statement Analysis – Financial Results
Complete financial analysis of Tenet Healthcare Corporation (THC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tenet Healthcare Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Mercato Partners Acquisition Corporation (MPRA) Income Statement Analysis – Financial Results
- KBS Real Estate Investment Trust III, Inc. (KBSR) Income Statement Analysis – Financial Results
- Standard Industries Limited (SIL.BO) Income Statement Analysis – Financial Results
- Soitec S.A. (SLOIF) Income Statement Analysis – Financial Results
- Ten Pao Group Holdings Limited (1979.HK) Income Statement Analysis – Financial Results
Tenet Healthcare Corporation (THC)
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of February 09, 2022, the company operated 60 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.55B | 19.17B | 19.49B | 17.64B | 18.48B | 18.31B | 19.18B | 19.62B | 18.63B | 16.62B | 11.10B | 9.12B | 8.85B | 9.21B | 9.01B | 8.66B | 8.85B | 8.70B | 9.61B | 9.92B | 13.21B | 0.00 | 12.05B | 11.41B | 10.88B | 9.90B | 8.69B | 5.56B | 3.32B | 2.97B | 3.76B | 3.98B | 3.81B | 3.94B | 3.68B | 3.20B | 2.88B | 3.60B |
| Cost of Revenue | 3.59B | 3.27B | 3.33B | 2.98B | 3.06B | 3.00B | 3.09B | 3.12B | 2.96B | 2.63B | 1.78B | 1.55B | 5.66B | 5.48B | 5.43B | 5.34B | 5.54B | 5.47B | 6.16B | 6.05B | 8.16B | 0.00 | 4.28B | 4.12B | 3.87B | 3.45B | 7.83B | 4.46B | 2.70B | 2.46B | 3.16B | 3.28B | 3.07B | 3.25B | 3.09B | 2.68B | 2.38B | 2.52B |
| Gross Profit | 16.96B | 15.90B | 16.16B | 14.66B | 15.42B | 15.31B | 16.09B | 16.50B | 15.67B | 13.99B | 9.32B | 7.57B | 3.19B | 3.73B | 3.59B | 3.32B | 3.32B | 3.23B | 3.45B | 3.87B | 5.06B | 0.00 | 7.77B | 7.29B | 7.01B | 6.45B | 857.00M | 1.10B | 623.00M | 512.00M | 598.80M | 706.00M | 741.00M | 683.00M | 583.00M | 522.00M | 505.00M | 1.08B |
| Gross Profit Ratio | 82.53% | 82.93% | 82.92% | 83.10% | 83.46% | 83.60% | 83.91% | 84.08% | 84.10% | 84.17% | 83.93% | 82.98% | 36.03% | 40.50% | 39.80% | 38.31% | 37.45% | 37.13% | 35.91% | 39.02% | 38.26% | 0.00% | 64.49% | 63.90% | 64.46% | 65.17% | 9.86% | 19.77% | 18.78% | 17.26% | 15.92% | 17.73% | 19.47% | 17.36% | 15.86% | 16.30% | 17.53% | 30.04% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.15B | 8.84B | 8.88B | 8.42B | 8.70B | 8.63B | 9.27B | 9.36B | 9.01B | 8.02B | 5.37B | 4.26B | 0.00 | 0.00 | 0.00 | 0.00 | 2.61B | 2.54B | 2.88B | 3.44B | 0.00 | 0.00 | 5.53B | 5.36B | 5.16B | 4.64B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.15B | 8.84B | 8.88B | 8.42B | 8.70B | 8.63B | 9.27B | 9.36B | 9.01B | 8.02B | 5.37B | 4.26B | 0.00 | 0.00 | 0.00 | 0.00 | 2.61B | 2.54B | 2.88B | 3.44B | 12.15B | 0.00 | 5.53B | 5.36B | 5.16B | 4.64B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 633.00M |
| Other Expenses | 5.30B | 4.65B | 4.87B | 4.10B | 5.04B | -5.00M | -22.00M | 5.71B | 5.28B | 4.86B | 3.15B | 2.54B | 2.46B | 3.07B | 1.08B | 1.01B | 432.00M | 1.47B | 919.00M | 1.71B | 2.62B | 0.00 | 697.00M | 533.00M | 556.00M | 460.00M | 443.00M | 321.00M | 195.00M | 198.00M | 199.00M | 196.00M | 172.00M | 170.00M | 157.00M | 139.00M | 129.00M | 130.00M |
| Operating Expenses | 14.45B | 13.49B | 13.75B | 12.52B | 13.74B | 13.69B | 14.71B | 15.07B | 14.29B | 12.88B | 8.52B | 6.79B | 2.46B | 3.07B | 1.08B | 3.00B | 3.05B | 4.01B | 3.80B | 5.15B | 14.77B | 0.00 | 6.23B | 5.89B | 5.71B | 5.10B | 443.00M | 321.00M | 195.00M | 198.00M | 199.00M | 196.00M | 172.00M | 170.00M | 157.00M | 139.00M | 129.00M | 763.00M |
| Cost & Expenses | 18.04B | 16.76B | 17.08B | 15.50B | 16.80B | 16.70B | 17.79B | 18.19B | 17.25B | 15.51B | 10.31B | 8.35B | 8.12B | 8.55B | 6.51B | 8.35B | 8.58B | 9.48B | 9.96B | 11.20B | 14.77B | 0.00 | 10.51B | 10.01B | 9.58B | 8.55B | 8.28B | 4.78B | 2.89B | 2.65B | 3.36B | 3.47B | 3.24B | 3.42B | 3.25B | 2.82B | 2.51B | 3.28B |
| Interest Income | 0.00 | 890.00M | 923.00M | 1.00B | 985.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 901.00M | 890.00M | 923.00M | 1.00B | 985.00M | 1.00B | 1.03B | 979.00M | 912.00M | 754.00M | 474.00M | 412.00M | 375.00M | 424.00M | 445.00M | 418.00M | 439.00M | 1.35B | 932.00M | 2.51B | 2.49B | 0.00 | 518.00M | 1.11B | 1.16B | 1.04B | 607.00M | 0.00 | 62.00M | 479.10M | 203.80M | 497.00M | 67.00M | 78.00M | 132.00M | 95.00M | 151.00M | 109.00M |
| Depreciation & Amortization | 870.00M | 841.00M | 855.00M | 857.00M | 850.00M | 802.00M | 870.00M | 850.00M | 797.00M | 849.00M | 545.00M | 430.00M | 413.00M | 425.00M | 386.00M | 373.00M | 362.00M | 342.00M | 382.00M | 388.00M | 471.00M | 0.00 | 554.00M | 533.00M | 556.00M | 460.00M | 443.00M | 321.00M | 195.00M | 198.00M | 199.00M | 196.00M | 172.00M | 170.00M | 157.00M | 139.00M | 129.00M | 130.00M |
| EBITDA | 3.39B | 3.33B | 3.42B | 2.43B | 2.90B | 2.79B | 2.54B | 2.56B | 2.20B | 1.94B | 1.33B | 1.18B | 960.00M | 973.00M | 1.04B | 843.00M | 659.00M | -378.00M | 311.00M | -905.00M | -611.00M | 0.00 | 2.18B | 2.22B | 2.19B | 2.03B | 848.00M | 797.00M | 575.00M | 396.00M | 661.80M | 894.00M | 711.00M | 653.00M | 556.00M | 496.00M | 482.00M | 424.00M |
| EBITDA Ratio | 16.49% | 18.14% | 17.94% | 17.95% | 14.61% | 14.00% | 12.41% | 12.30% | 12.21% | 11.75% | 12.09% | 13.19% | 12.93% | 11.74% | 32.07% | 8.16% | 7.39% | 7.17% | 5.40% | 4.44% | 7.89% | 0.00% | 18.08% | 19.44% | 20.17% | 20.46% | 9.76% | 14.34% | 17.33% | 13.35% | 17.59% | 22.45% | 18.68% | 16.59% | 15.13% | 15.49% | 16.73% | 11.79% |
| Operating Income | 2.51B | 2.33B | 2.87B | 1.99B | 1.51B | 1.65B | 1.11B | 1.22B | 1.06B | 925.00M | 663.00M | 749.00M | 732.00M | 656.00M | 2.51B | 2.31B | 292.00M | 282.00M | 137.00M | 52.00M | 572.00M | 0.00 | 1.63B | 1.69B | 1.64B | 1.57B | 405.00M | 476.00M | 380.00M | 198.00M | 462.80M | 698.00M | 539.00M | 483.00M | 399.00M | 357.00M | 353.00M | 294.00M |
| Operating Income Ratio | 12.22% | 12.17% | 14.73% | 11.28% | 8.19% | 8.99% | 5.80% | 6.21% | 5.67% | 5.57% | 5.97% | 8.21% | 8.27% | 7.13% | 27.79% | 26.71% | 3.30% | 3.24% | 1.43% | 0.52% | 4.33% | 0.00% | 13.48% | 14.77% | 15.06% | 15.82% | 4.66% | 8.56% | 11.45% | 6.67% | 12.30% | 17.53% | 14.16% | 12.27% | 10.85% | 11.15% | 12.25% | 8.18% |
| Total Other Income/Expenses | -893.00M | -989.00M | -983.00M | -1.32B | -1.22B | -1.01B | -1.21B | -999.00M | -933.00M | -778.00M | -821.00M | -415.00M | -492.00M | -476.00M | -391.00M | -246.00M | -388.00M | -342.00M | -524.00M | -424.00M | -403.00M | 0.00 | 136.00M | -405.00M | -784.00M | -828.00M | 242.00M | -435.00M | -57.00M | -99.00M | -102.90M | -140.80M | -280.00M | -11.00M | 6.00M | -41.00M | -99.00M | -15.00M |
| Income Before Tax | 1.62B | 1.34B | 1.89B | 671.00M | 296.00M | 639.00M | -101.00M | 248.00M | 144.00M | 147.00M | -158.00M | 334.00M | 161.00M | 158.00M | 205.00M | 37.00M | -107.00M | -1.13B | -708.00M | -1.61B | -1.84B | 0.00 | 1.14B | 618.00M | 474.00M | 647.00M | -21.00M | 746.00M | 329.00M | 359.90M | 259.00M | 230.00M | 472.00M | 405.00M | 316.00M | 284.00M | 279.00M | 209.00M |
| Income Before Tax Ratio | 7.87% | 7.01% | 9.69% | 3.80% | 1.60% | 3.49% | -0.53% | 1.26% | 0.77% | 0.88% | -1.42% | 3.66% | 1.82% | 1.72% | 2.27% | 0.43% | -1.21% | -13.02% | -7.36% | -16.26% | -13.93% | 0.00% | 9.47% | 5.41% | 4.36% | 6.54% | -0.24% | 13.42% | 9.92% | 12.13% | 6.89% | 5.78% | 12.40% | 10.29% | 8.60% | 8.87% | 9.68% | 5.81% |
| Income Tax Expense | 306.00M | 344.00M | 411.00M | -97.00M | 153.00M | 176.00M | 219.00M | 67.00M | 68.00M | 49.00M | -65.00M | 125.00M | 61.00M | -977.00M | -23.00M | -25.00M | -58.00M | -262.00M | -87.00M | 184.00M | -437.00M | 0.00 | 464.00M | 278.00M | 225.00M | 269.00M | 52.00M | 348.00M | 135.00M | 144.00M | 99.00M | 97.00M | 195.00M | 163.00M | 124.00M | 114.00M | 139.00M | 91.00M |
| Net Income | 611.00M | 1.00B | 1.48B | 768.00M | 143.00M | 111.00M | -704.00M | -192.00M | -140.00M | 12.00M | -134.00M | 152.00M | 82.00M | 1.14B | 187.00M | 25.00M | -89.00M | -803.00M | -708.00M | -2.64B | -1.48B | 0.00 | 785.00M | 302.00M | 249.00M | 261.00M | -254.00M | 349.80M | 183.00M | -425.10M | 160.00M | 104.00M | 277.00M | 242.00M | 143.00M | 148.00M | 63.00M | 94.00M |
| Net Income Ratio | 2.97% | 5.22% | 7.58% | 4.35% | 0.77% | 0.61% | -3.67% | -0.98% | -0.75% | 0.07% | -1.21% | 1.67% | 0.93% | 12.42% | 2.07% | 0.29% | -1.01% | -9.23% | -7.36% | -26.62% | -11.18% | 0.00% | 6.51% | 2.65% | 2.29% | 2.64% | -2.92% | 6.29% | 5.52% | -14.33% | 4.25% | 2.61% | 7.28% | 6.15% | 3.89% | 4.62% | 2.19% | 2.61% |
| EPS | 5.88 | 9.35 | 13.83 | 7.31 | 1.38 | 1.09 | -7.00 | -1.93 | -1.41 | 0.12 | -1.32 | 1.35 | 0.49 | 9.24 | 1.52 | 0.20 | -0.75 | -6.82 | -6.04 | -22.65 | -12.67 | 0.00 | 5.36 | 2.58 | 2.14 | 2.27 | -2.23 | 4.52 | 2.76 | -6.79 | 2.56 | 1.60 | 4.62 | 4.06 | 2.56 | 2.67 | 1.09 | 1.57 |
| EPS Diluted | 5.71 | 9.05 | 13.60 | 7.23 | 1.38 | 1.07 | -7.00 | -1.93 | -1.41 | 0.12 | -1.32 | 1.30 | 0.48 | 8.16 | 1.48 | 0.20 | -0.75 | -6.82 | -6.04 | -22.65 | -12.67 | 0.00 | 5.25 | 2.56 | 2.12 | 2.23 | -2.23 | 4.37 | 2.43 | -6.79 | 2.43 | 1.60 | 4.11 | 3.58 | 2.40 | 2.45 | 1.09 | 1.57 |
| Weighted Avg Shares Out | 101.64M | 106.93M | 106.83M | 105.01M | 103.40M | 102.11M | 100.57M | 99.32M | 99.17M | 97.80M | 101.65M | 104.20M | 117.18M | 121.08M | 120.06M | 119.09M | 118.35M | 117.71M | 117.22M | 116.56M | 116.60M | 116.48M | 119.91M | 116.99M | 116.27M | 115.02M | 113.95M | 77.42M | 66.31M | 62.63M | 62.47M | 64.97M | 60.01M | 59.67M | 55.83M | 55.47M | 57.59M | 59.72M |
| Weighted Avg Shares Out (Dil) | 104.80M | 110.52M | 108.57M | 106.26M | 103.40M | 103.88M | 100.59M | 99.32M | 99.17M | 100.29M | 101.65M | 108.93M | 121.30M | 140.16M | 126.82M | 119.65M | 118.35M | 117.71M | 117.22M | 116.56M | 116.60M | 116.48M | 122.68M | 118.09M | 117.52M | 116.80M | 114.06M | 80.09M | 75.41M | 62.63M | 65.90M | 64.97M | 67.42M | 67.69M | 59.55M | 60.30M | 57.59M | 59.72M |
Bull of the Day: Tenet Healthcare (THC)
Tenet Healthcare shares have been scorching-hot in 2024, up 115% and outperforming many of the Mag 7 members.
Tenet (THC) Is Attractively Priced Despite Fast-paced Momentum
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Tenet Healthcare is currently shifting towards a more stable demand for high-acuity service. The company is committed to continued expansion and allocated yearly budget to improve its Ambulatory Care Services. Posted an improving margin and has positive outlook from the...
Tenet Q3 Earnings Beat on Strong Ambulatory Unit, '24 EPS View Raised
THC's Q3 results benefit from higher same-hospital admissions and Medicaid supplemental revenue gains. Cost-cutting measures help offset challenges from hospital divestitures.
Play Likely Earnings Beat With 4 Top-Ranked Stocks
Top-ranked stocks Tenet Healthcare (THC), Fortinet (FTNT), Leidos (LDOS) and American Airlines (AAL) are likely to beat on the bottom line in their upcoming releases.
New Strong Buy Stocks for November 1st
SKY, AAT, SOHO, THC and LDOS have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2024.
Here's Why Tenet Healthcare (THC) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Stocks to Buy Following Robust Quarterly Results
Throughout the Q3 reporting cycle, several companies, including Pfizer, Philip Morris, and Tenet Healthcare, have stolen the spotlight, with each raising guidance.
Tenet Healthcare Corporation (THC) Q3 2024 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q3 2024 Earnings Conference Call October 29, 2024 10:00 AM ET Company Participants Will McDowell – Vice President-Investor Relations Saum Sutaria – Chairman and Chief Executive Officer Sun Park – Executive Vice President and Chief...
Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Source: https://incomestatements.info
Category: Stock Reports